Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention

Pierluigi Tricoci, L. Kristin Newby, Robert M. Clare, Sergio Leonardi, C. Michael Gibson, Robert P. Giugliano, Paul W. Armstrong, Frans Van de Werf, Gilles Montalescot, David J. Moliterno, Claes Held, Philip E. Aylward, Lars Wallentin, Robert A. Harrington, Eugene Braunwald, Kenneth W. Mahaffey, Harvey D. White

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: In 13,038 patients with non–ST-segment elevation acute coronary syndrome undergoing index percutaneous coronary intervention (PCI) in the EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) and TRACER (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome) trials, the relationship between PCI-related myocardial infarction (MI) and 1-year mortality was assessed. Background: The definition of PCI-related MI is controversial. The third universal definition of PCI-related MI requires cardiac troponin >5 times the 99th percentile of the normal reference limit from a stable or falling baseline and PCI-related clinical or angiographic complications. The definition from the Society for Cardiovascular Angiography and Interventions (SCAI) requires creatine kinase–MB elevation >10 times the upper limit of normal (or 5 times if new electrocardiographic Q waves are present). Implications of these definitions on prognosis, prevalence, and implementation are not established. Methods: In our cohort of patients undergoing PCI, PCI-related MIs were classified using the third universal type 4a MI definition and SCAI criteria. In the subgroup of patients included in the angiographic core laboratory (ACL) substudy of EARLY ACS (n = 1,401) local investigator– versus ACL-reported angiographic complications were compared. Results: Altogether, 2.0% of patients met third universal definition of PCI-related MI criteria, and 1.2% met SCAI criteria. One-year mortality was 3.3% with the third universal definition (hazard ratio: 1.96; 95% confidence interval: 1.24 to 3.10) and 5.3% with SCAI criteria (hazard ratio: 2.79; 95% confidence interval: 1.69 to 4.58; p < 0.001). Agreement between ACL and local investigators in detecting angiographic complications during PCI was overall moderate (κ = 0.53). Conclusions: The third universal definition of MI and the SCAI definition were both associated with significant risk for mortality at 1 year. Suboptimal concordance was observed between ACL and local investigators in identifying patients with PCI complications detected on angiography. (Trial to Assess the Effects of Vorapaxar [SCH 530348; MK-5348] in Preventing Heart Attack and Stroke in Participants With Acute Coronary Syndrome [TRA·CER] [Study P04736]; NCT00527943; EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome [Study P03684AM2]; NCT00089895)

Original languageEnglish
Pages (from-to)856-864
Number of pages9
JournalJACC: Cardiovascular Interventions
Volume11
Issue number9
DOIs
Publication statusPublished - May 14 2018

Fingerprint

Percutaneous Coronary Intervention
Myocardial Infarction
Acute Coronary Syndrome
Angiography
Platelet Glycoprotein GPIIb-IIIa Complex
Research Personnel
Mortality
Confidence Intervals
Thrombin Receptors
Troponin
Creatine
Stroke

Keywords

  • acute coronary syndrome(s)
  • definitions
  • myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention. / Tricoci, Pierluigi; Newby, L. Kristin; Clare, Robert M.; Leonardi, Sergio; Gibson, C. Michael; Giugliano, Robert P.; Armstrong, Paul W.; Van de Werf, Frans; Montalescot, Gilles; Moliterno, David J.; Held, Claes; Aylward, Philip E.; Wallentin, Lars; Harrington, Robert A.; Braunwald, Eugene; Mahaffey, Kenneth W.; White, Harvey D.

In: JACC: Cardiovascular Interventions, Vol. 11, No. 9, 14.05.2018, p. 856-864.

Research output: Contribution to journalArticle

Tricoci, P, Newby, LK, Clare, RM, Leonardi, S, Gibson, CM, Giugliano, RP, Armstrong, PW, Van de Werf, F, Montalescot, G, Moliterno, DJ, Held, C, Aylward, PE, Wallentin, L, Harrington, RA, Braunwald, E, Mahaffey, KW & White, HD 2018, 'Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention', JACC: Cardiovascular Interventions, vol. 11, no. 9, pp. 856-864. https://doi.org/10.1016/j.jcin.2018.02.006
Tricoci, Pierluigi ; Newby, L. Kristin ; Clare, Robert M. ; Leonardi, Sergio ; Gibson, C. Michael ; Giugliano, Robert P. ; Armstrong, Paul W. ; Van de Werf, Frans ; Montalescot, Gilles ; Moliterno, David J. ; Held, Claes ; Aylward, Philip E. ; Wallentin, Lars ; Harrington, Robert A. ; Braunwald, Eugene ; Mahaffey, Kenneth W. ; White, Harvey D. / Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention. In: JACC: Cardiovascular Interventions. 2018 ; Vol. 11, No. 9. pp. 856-864.
@article{6f1346ba278e402c843ed1032f420903,
title = "Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention",
abstract = "Objectives: In 13,038 patients with non–ST-segment elevation acute coronary syndrome undergoing index percutaneous coronary intervention (PCI) in the EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) and TRACER (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome) trials, the relationship between PCI-related myocardial infarction (MI) and 1-year mortality was assessed. Background: The definition of PCI-related MI is controversial. The third universal definition of PCI-related MI requires cardiac troponin >5 times the 99th percentile of the normal reference limit from a stable or falling baseline and PCI-related clinical or angiographic complications. The definition from the Society for Cardiovascular Angiography and Interventions (SCAI) requires creatine kinase–MB elevation >10 times the upper limit of normal (or 5 times if new electrocardiographic Q waves are present). Implications of these definitions on prognosis, prevalence, and implementation are not established. Methods: In our cohort of patients undergoing PCI, PCI-related MIs were classified using the third universal type 4a MI definition and SCAI criteria. In the subgroup of patients included in the angiographic core laboratory (ACL) substudy of EARLY ACS (n = 1,401) local investigator– versus ACL-reported angiographic complications were compared. Results: Altogether, 2.0{\%} of patients met third universal definition of PCI-related MI criteria, and 1.2{\%} met SCAI criteria. One-year mortality was 3.3{\%} with the third universal definition (hazard ratio: 1.96; 95{\%} confidence interval: 1.24 to 3.10) and 5.3{\%} with SCAI criteria (hazard ratio: 2.79; 95{\%} confidence interval: 1.69 to 4.58; p < 0.001). Agreement between ACL and local investigators in detecting angiographic complications during PCI was overall moderate (κ = 0.53). Conclusions: The third universal definition of MI and the SCAI definition were both associated with significant risk for mortality at 1 year. Suboptimal concordance was observed between ACL and local investigators in identifying patients with PCI complications detected on angiography. (Trial to Assess the Effects of Vorapaxar [SCH 530348; MK-5348] in Preventing Heart Attack and Stroke in Participants With Acute Coronary Syndrome [TRA·CER] [Study P04736]; NCT00527943; EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome [Study P03684AM2]; NCT00089895)",
keywords = "acute coronary syndrome(s), definitions, myocardial infarction",
author = "Pierluigi Tricoci and Newby, {L. Kristin} and Clare, {Robert M.} and Sergio Leonardi and Gibson, {C. Michael} and Giugliano, {Robert P.} and Armstrong, {Paul W.} and {Van de Werf}, Frans and Gilles Montalescot and Moliterno, {David J.} and Claes Held and Aylward, {Philip E.} and Lars Wallentin and Harrington, {Robert A.} and Eugene Braunwald and Mahaffey, {Kenneth W.} and White, {Harvey D.}",
year = "2018",
month = "5",
day = "14",
doi = "10.1016/j.jcin.2018.02.006",
language = "English",
volume = "11",
pages = "856--864",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention

AU - Tricoci, Pierluigi

AU - Newby, L. Kristin

AU - Clare, Robert M.

AU - Leonardi, Sergio

AU - Gibson, C. Michael

AU - Giugliano, Robert P.

AU - Armstrong, Paul W.

AU - Van de Werf, Frans

AU - Montalescot, Gilles

AU - Moliterno, David J.

AU - Held, Claes

AU - Aylward, Philip E.

AU - Wallentin, Lars

AU - Harrington, Robert A.

AU - Braunwald, Eugene

AU - Mahaffey, Kenneth W.

AU - White, Harvey D.

PY - 2018/5/14

Y1 - 2018/5/14

N2 - Objectives: In 13,038 patients with non–ST-segment elevation acute coronary syndrome undergoing index percutaneous coronary intervention (PCI) in the EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) and TRACER (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome) trials, the relationship between PCI-related myocardial infarction (MI) and 1-year mortality was assessed. Background: The definition of PCI-related MI is controversial. The third universal definition of PCI-related MI requires cardiac troponin >5 times the 99th percentile of the normal reference limit from a stable or falling baseline and PCI-related clinical or angiographic complications. The definition from the Society for Cardiovascular Angiography and Interventions (SCAI) requires creatine kinase–MB elevation >10 times the upper limit of normal (or 5 times if new electrocardiographic Q waves are present). Implications of these definitions on prognosis, prevalence, and implementation are not established. Methods: In our cohort of patients undergoing PCI, PCI-related MIs were classified using the third universal type 4a MI definition and SCAI criteria. In the subgroup of patients included in the angiographic core laboratory (ACL) substudy of EARLY ACS (n = 1,401) local investigator– versus ACL-reported angiographic complications were compared. Results: Altogether, 2.0% of patients met third universal definition of PCI-related MI criteria, and 1.2% met SCAI criteria. One-year mortality was 3.3% with the third universal definition (hazard ratio: 1.96; 95% confidence interval: 1.24 to 3.10) and 5.3% with SCAI criteria (hazard ratio: 2.79; 95% confidence interval: 1.69 to 4.58; p < 0.001). Agreement between ACL and local investigators in detecting angiographic complications during PCI was overall moderate (κ = 0.53). Conclusions: The third universal definition of MI and the SCAI definition were both associated with significant risk for mortality at 1 year. Suboptimal concordance was observed between ACL and local investigators in identifying patients with PCI complications detected on angiography. (Trial to Assess the Effects of Vorapaxar [SCH 530348; MK-5348] in Preventing Heart Attack and Stroke in Participants With Acute Coronary Syndrome [TRA·CER] [Study P04736]; NCT00527943; EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome [Study P03684AM2]; NCT00089895)

AB - Objectives: In 13,038 patients with non–ST-segment elevation acute coronary syndrome undergoing index percutaneous coronary intervention (PCI) in the EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) and TRACER (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome) trials, the relationship between PCI-related myocardial infarction (MI) and 1-year mortality was assessed. Background: The definition of PCI-related MI is controversial. The third universal definition of PCI-related MI requires cardiac troponin >5 times the 99th percentile of the normal reference limit from a stable or falling baseline and PCI-related clinical or angiographic complications. The definition from the Society for Cardiovascular Angiography and Interventions (SCAI) requires creatine kinase–MB elevation >10 times the upper limit of normal (or 5 times if new electrocardiographic Q waves are present). Implications of these definitions on prognosis, prevalence, and implementation are not established. Methods: In our cohort of patients undergoing PCI, PCI-related MIs were classified using the third universal type 4a MI definition and SCAI criteria. In the subgroup of patients included in the angiographic core laboratory (ACL) substudy of EARLY ACS (n = 1,401) local investigator– versus ACL-reported angiographic complications were compared. Results: Altogether, 2.0% of patients met third universal definition of PCI-related MI criteria, and 1.2% met SCAI criteria. One-year mortality was 3.3% with the third universal definition (hazard ratio: 1.96; 95% confidence interval: 1.24 to 3.10) and 5.3% with SCAI criteria (hazard ratio: 2.79; 95% confidence interval: 1.69 to 4.58; p < 0.001). Agreement between ACL and local investigators in detecting angiographic complications during PCI was overall moderate (κ = 0.53). Conclusions: The third universal definition of MI and the SCAI definition were both associated with significant risk for mortality at 1 year. Suboptimal concordance was observed between ACL and local investigators in identifying patients with PCI complications detected on angiography. (Trial to Assess the Effects of Vorapaxar [SCH 530348; MK-5348] in Preventing Heart Attack and Stroke in Participants With Acute Coronary Syndrome [TRA·CER] [Study P04736]; NCT00527943; EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome [Study P03684AM2]; NCT00089895)

KW - acute coronary syndrome(s)

KW - definitions

KW - myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=85046454117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046454117&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2018.02.006

DO - 10.1016/j.jcin.2018.02.006

M3 - Article

AN - SCOPUS:85046454117

VL - 11

SP - 856

EP - 864

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 9

ER -